Mutation Asn-21 3 Ile in human cationic trypsinogen (Tg-1) has been associated with hereditary pancreatitis. Recent studies with rat anionic Tg (Tg-2) indicated that the analogous Thr-21 3 Ile mutation stabilizes the zymogen against autoactivation, whereas it has no effect on catalytic properties or autolytic stability of trypsin (Sahin-Tó th, M. (1999) J. Biol. Chem. 274, 29699 -29704). In the present paper, human cationic Tg (Asn-21-Tg) and mutants Asn-21 3 Ile (Ile-21-Tg) and Asn-21 3 Thr (Thr-21-Tg) were expressed in Escherichia coli, and zymogen activation, zymogen degradation, and trypsin autolysis were studied. Enterokinase activated Asn-21-Tg approximately 2-fold better than Ile-21-Tg or Thr-21-Tg, and catalytic parameters of trypsins were comparable. At 37°C, in 5 mM Ca 2؉ , all three trypsins were highly stable. In the absence of Ca 2؉ , Asn-21-and Ile-21-trypsins suffered autolysis in an indistinguishable manner, whereas Thr-21-trypsin exhibited significantly increased stability. In sharp contrast to observations with the rat proenzyme, at pH 8.0, 37°C, autoactivation kinetics of Asn-21-Tg and Ile-21-Tg were identical; however, at pH 5.0, Ile-21-Tg autoactivated at an enhanced rate relative to Asn-21-Tg. Remarkably, at both pH values, Thr-21-Tg showed markedly higher autoactivation rates than the two other zymogens. Finally, autocatalytic proteolysis of human zymogens was limited to cleavage at Arg-117, and no digestion at Lys-188 was detected. The observations indicate that zymogen stabilization by Ile-21 as observed in rat Tg-2 is not characteristic of human Tg-1. Instead, an increased propensity to autoactivation under acidic conditions might be relevant to the pathomechanism of the Asn-21 3 Ile mutation in hereditary pancreatitis. In the same context, faster autoactivation and increased trypsin stability caused by the Asn-21 3 Thr mutation in human Tg-1 might provide a rationale for the evolutionary divergence from Thr-21 found in other mammalian trypsinogens.
Hereditary pancreatitis (HP)1 is a relatively rare autosomal dominant disorder, characterized by early onset episodes of acute pancreatitis with frequent progression to chronic pancreatitis (1-4). Two mutations in the cationic trypsinogen (Tg) gene, Arg-117 3 His and Asn-21 3 Ile, have been identified in patients affected by HP worldwide (2-10). It has been proposed that mutation Arg-117 3 His eliminates a trypsin-sensitive cleavage site on trypsin and leads to pancreatitis by rendering prematurely activated trypsin resistant to inactivation through autolysis or proteolysis by trypsin-like enzymes (5). Degradation of trypsin by such mechanisms in the pancreas is believed to serve as a fail-safe mechanism against excessive trypsin accumulation (11-13). Although direct biochemical evidence with recombinant human cationic Tg is still lacking, Arg-117 has been shown to be a critical autolysis site in bovine (14) as well as rat (15) anionic trypsin, and mutations of this residue stabilize rat anionic trypsin against autolysis (16 -18). Arg-117 is...